GlassScriptPhysician profile
James L Rose
NPI 1891891644
$1,543.57
in general payments reported to CMS, 2019-2025
28 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2021: $118 · 2022: $222 · 2023: $223 · 2024: $433 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $246.09 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix |
| Paratek Pharmaceuticals, INC. | $228.03 | 2022-2025 | Nuzyra |
| Organogenesis INC. | $154.66 | 2021-2025 | Affinity |
| Convatec INC. | $90.09 | 2023-2024 | |
| Globus Medical, INC. | $87.11 | 2025 | Senza |
| Boston Scientific Corporation | $69.27 | 2023-2024 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Nevro Corp. | $68.37 | 2023-2024 | Senza |
| Bioventus LLC | $65.12 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $58.72 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $57.82 | 2021-2024 | Jublia, Cabtreo |
| Kowa Pharmaceuticals America, INC. | $47.89 | 2022 | |
| Wright Medical Technology, INC. | $36.24 | 2019 | |
| Abbvie INC. | $33.35 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $30.55 | 2025 | Purified Cortrophin Gel |
| Stryker Corporation | $30.22 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $24.79 | 2023 | Portfolio |
| Polynovo North America LLC | $22.31 | 2024 | Novosorb Btm |
| Acera Surgical, INC. | $22.19 | 2025 | Restrata Wound Matrix |
| Osiris Therapeutics INC. | $21.67 | 2019 | |
| Sandoz INC. | $21.11 | 2019 | |
| Medtronic, INC. | $20.50 | 2024 | Intellis Adaptivestim |
| Treace Medical Concepts, INC. | $19.71 | 2025 | |
| Zimmer Biomet Holdings, INC. | $17.03 | 2022 | |
| Heron Therapeutics, INC. | $16.50 | 2021 | |
| Fidia Pharma USA INC. | $16.19 | 2019 | |
| Innovation Technologies INC | $14.92 | 2025 | Irrisept |
| Musculoskeletal Transplant Foundation INC. | $11.57 | 2019 | |
| Novum Pharma, LLC | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.